News | November 27, 2025
Valneva shifts French ops to Lyon
Valneva will consolidate its French operations at its Lyon site and close its Nantes location
Valneva will consolidate its French operations at its Lyon site and close its Nantes location
The deal, backed by Gavi and executed by UNICEF, could generate up to US$90 million in savings—enough to provide more than 30 million additional doses
The new Bioprocess Design Center will serve as a cutting-edge scale-up hub for biologics and vaccine manufacturing
Globally, Abbott has received reports of 736 severe adverse events linked to the issue, including seven deaths (none in the US)
The collaboration aims to make Alzheimer’s biomarker testing more accessible and less intimidating
The deliveries bring the innovative medicine to communities heavily impacted by HIV just five months after U.S. FDA approval
The proposed transaction will be effected as a share swap
These certifications reflect the company's continuous commitment to maintaining international standards of environmental sustainability as well as occupational health and safety
Millions of stroke survivors across the world may soon have a new defense
The therapy -- Ryoncil (remestemcel-L-rknd) -- will be tested in adults with severe steroid-refractory acute graft-versus-host disease
Subscribe To Our Newsletter & Stay Updated
